Biomarkers of gemcitabine and erlotinib treatment in advanced pancreatic cancer
Latest Information Update: 10 Dec 2015
At a glance
- Drugs Erlotinib (Primary) ; Gemcitabine (Primary)
- Indications Pancreatic cancer
- Focus Biomarker; Therapeutic Use
Most Recent Events
- 10 Dec 2015 New trial record